Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aqueous amiodarone - Academic Pharmaceuticals

Next Previous
Drug Profile

Aqueous amiodarone - Academic Pharmaceuticals

Alternative Names: Amio-Aqueous

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Academic Pharmaceuticals
  • Class Benzofurans; Class III antiarrhythmics; Heart failure therapies; Small molecules
  • Mechanism of Action Beta adrenergic receptor antagonists; KATP channel inhibitors; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ventricular tachycardia
  • New Molecular Entity No

Highest Development Phases

  • No development reported Supraventricular arrhythmias; Ventricular tachycardia

Most Recent Events

  • 08 Jun 2010 No development reported - Phase-III for Supraventricular arrhythmias in USA (IV)
  • 08 Jun 2010 No development reported - Phase-III for Ventricular tachycardia in USA (IV)
  • 24 Oct 2007 Phase-III clinical trials in Supraventricular arrhythmias in USA (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top